Göran Samsioe MD , Martina Dören MD , Rogerio A Lobo MD
{"title":"激素替代疗法","authors":"Göran Samsioe MD , Martina Dören MD , Rogerio A Lobo MD","doi":"10.1053/S1744-1870(06)70207-4","DOIUrl":null,"url":null,"abstract":"<div><p>Hormone Therapy (HT) is a valid option for women with climacteric symptoms. At present there is a controversy as to whether HT should be used chronically for prevention to each patient. This review investigates the basic use of oestrogens, progestogens, the HT regimens, bleeding problems in HT users and when HT is necessary.</p></div>","PeriodicalId":101284,"journal":{"name":"Women's Health Medicine","volume":"3 5","pages":"Pages 213-216"},"PeriodicalIF":0.0000,"publicationDate":"2006-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1053/S1744-1870(06)70207-4","citationCount":"0","resultStr":"{\"title\":\"Hormone replacement therapy – the agents\",\"authors\":\"Göran Samsioe MD , Martina Dören MD , Rogerio A Lobo MD\",\"doi\":\"10.1053/S1744-1870(06)70207-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Hormone Therapy (HT) is a valid option for women with climacteric symptoms. At present there is a controversy as to whether HT should be used chronically for prevention to each patient. This review investigates the basic use of oestrogens, progestogens, the HT regimens, bleeding problems in HT users and when HT is necessary.</p></div>\",\"PeriodicalId\":101284,\"journal\":{\"name\":\"Women's Health Medicine\",\"volume\":\"3 5\",\"pages\":\"Pages 213-216\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2006-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1053/S1744-1870(06)70207-4\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Women's Health Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1744187006702074\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Women's Health Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1744187006702074","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Hormone Therapy (HT) is a valid option for women with climacteric symptoms. At present there is a controversy as to whether HT should be used chronically for prevention to each patient. This review investigates the basic use of oestrogens, progestogens, the HT regimens, bleeding problems in HT users and when HT is necessary.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
